A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer

被引:194
|
作者
Silvestri, Gerard A. [1 ]
Vachani, Anil [2 ]
Whitney, Duncan [3 ,5 ]
Elashoff, Michael [6 ]
Smith, Kate Porta [3 ,5 ]
Ferguson, J. Scott [7 ]
Parsons, Ed [3 ]
Mitra, Nandita [2 ]
Brody, Jerome [4 ]
Lenburg, Marc E. [4 ]
Spira, Avrum [4 ]
机构
[1] Med Univ S Carolina, Charleston, SC USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Allegro Diagnost, Maynard, MA USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Veracyte, San Francisco, CA USA
[6] Elashoff Consulting, Redwood City, CA USA
[7] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 373卷 / 03期
基金
美国国家卫生研究院;
关键词
AMERICAN-COLLEGE; GENE-EXPRESSION; NODULES; MANAGEMENT; PREDICTION; GUIDELINES; BIOPSY;
D O I
10.1056/NEJMoa1504601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Bronchoscopy is frequently nondiagnostic in patients with pulmonary lesions suspected to be lung cancer. This often results in additional invasive testing, although many lesions are benign. We sought to validate a bronchial-airway gene-expression classifier that could improve the diagnostic performance of bronchoscopy. METHODS Current or former smokers undergoing bronchoscopy for suspected lung cancer were enrolled at 28 centers in two multicenter prospective studies (AEGIS-1 and AEGIS-2). A gene-expression classifier was measured in epithelial cells collected from the normal-appearing mainstem bronchus to assess the probability of lung cancer. RESULTS A total of 639 patients in AEGIS-1 (298 patients) and AEGIS-2 (341 patients) met the criteria for inclusion. A total of 43% of bronchoscopic examinations were nondiagnostic for lung cancer, and invasive procedures were performed after bronchoscopy in 35% of patients with benign lesions. In AEGIS-1, the classifier had an area under the receiver-operating-characteristic curve (AUC) of 0.78 (95% confidence interval [CI], 0.73 to 0.83), a sensitivity of 88% (95% CI, 83 to 92), and a specificity of 47% (95% CI, 37 to 58). In AEGIS-2, the classifier had an AUC of 0.74 (95% CI, 0.68 to 0.80), a sensitivity of 89% (95% CI, 84 to 92), and a specificity of 47% (95% CI, 36 to 59). The combination of the classifier plus bronchoscopy had a sensitivity of 96% (95% CI, 93 to 98) in AEGIS-1 and 98% (95% CI, 96 to 99) in AEGIS-2, independent of lesion size and location. In 101 patients with an intermediate pretest probability of cancer, the negative predictive value of the classifier was 91% (95% CI, 75 to 98) among patients with a nondiagnostic bronchoscopic examination. CONCLUSIONS The gene-expression classifier improved the diagnostic performance of bronchoscopy for the detection of lung cancer. In intermediate-risk patients with a nondiagnostic bronchoscopic examination, a negative classifier score provides support for a more conservative diagnostic approach.
引用
下载
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [41] Potential diagnostic markers in bronchial fluid of small cell lung cancer (SCLC)
    Lopez-Vivanco Guillermo
    Carrera, Sergio
    Calvo, Begona
    Munoz, Alberto
    Rubio, Itziar
    Zalacain, Rafael
    Gomez, Ainhoa
    Algorta, Jaime
    Simon, Laureano
    Uribarri, Maria
    Jangi, Muhialdin
    Ruiz de Lobera, Abigail
    Ballesteros, David
    Fuente, Natalia
    Casas, Raquel
    Lopez de Argumedo, Gonzalo
    Iruarrizaga, Eluska
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S870 - S870
  • [42] NEUROENDOCRINE AND EPITHELIAL MARKERS IN DIAGNOSTIC BRONCHIAL LUNG-CANCER BIOPSY SPECIMENS
    BURNETT, HE
    ZAKHOUR, HD
    WALKER, C
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 853 - 855
  • [43] Virtual tracheo-bronchial endoscopy: Educational and diagnostic value in lung cancer
    Buthiau, D
    Antoine, E
    Nizri, D
    Khayat, D
    Piette, JC
    Baldeyrou, P
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 19 - 26
  • [44] Potential diagnostic markers in bronchial fluid of small cell lung cancer (SCLC)
    Lopez Vivanco, G.
    Sergio Carrera, S.
    Simon, L.
    Gomez Bonilla, A.
    Martinez Bueno, A.
    Ballesteros Quintanilla, D.
    Zalacain Jorge, R.
    Marrodan Ciordia, I.
    Buque Martinez, A.
    Azkona Uribelarrea, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 150 - 151
  • [45] Cytology of bronchial biopsy rinse fluid to improve the diagnostic yield for lung cancer
    Rosell, A
    Monsó, E
    Lores, L
    Vilà, X
    Llatjós, M
    Ruiz, J
    Morera, J
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (06) : 1415 - 1418
  • [46] DIAGNOSTIC MARKERS IN BRONCHIAL FLUID OF LUNG CANCER PATIENTS; IMMUNOASSAY DEVELOPMENT AND VALIDATION
    Carrera, S.
    Lopez-Vivanco, G.
    Fernandez, R.
    Ruiz De Lobera, A.
    Zalacain, R.
    Rubio, I.
    Casas, R.
    Gomez, A.
    Mielgo, X.
    Marrodan, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 64 - 64
  • [47] BRONCHIAL BRUSHING AND BRONCHIAL BIOPSY - COMPARISON OF DIAGNOSTIC-ACCURACY AND CELL TYPING RELIABILITY IN LUNG-CANCER
    MATSUDA, M
    HORAI, T
    NAKAMURA, S
    NISHIO, H
    SAKUMA, T
    IKEGAMI, H
    TATEISHI, R
    THORAX, 1986, 41 (06) : 475 - 478
  • [48] A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells
    Yeo, Jiyoun
    Crawford, Erin L.
    Zhang, Xiaolu
    Khuder, Sadik
    Chen, Tian
    Levin, Albert
    Blomquist, Thomas M.
    Willey, James C.
    BMC CANCER, 2017, 17
  • [49] A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells
    Jiyoun Yeo
    Erin L. Crawford
    Xiaolu Zhang
    Sadik Khuder
    Tian Chen
    Albert Levin
    Thomas M. Blomquist
    James C. Willey
    BMC Cancer, 17
  • [50] A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells
    Yeo, Jiyoun
    Crawford, Erin
    Zhang, Xiaolu
    Khuder, Sadik
    Chen, Tian
    Levin, Albert
    Blomquist, Thomas
    Willey, James
    CANCER RESEARCH, 2017, 77